3 ms·
I doubt the US will see much of this, but this is now one of at least 4 high quality vaccines with great, public data banned from use in the US: Astrazeneca, J
by mchusma 6y ago
I doubt the US will see much of this, but this is now one of at least 4 high quality vaccines with great, public data banned from use in the US:
Astrazeneca, J&J, Novavax, and Sputnik V.
- zaphod12 6y agoJ&J only announced phase 3 results a few days ago and will be up for approval shortly. the Astrazenaca vaccine's results were a mess of p-hacking and mixing methods (they reported a result on a half-size first dose which occurred by accident and in a non-representative population because it looked good). Personally it makes me more confident in the FDA that they have yet to approve that vaccine.
- ls612 6y agoThe AZ vaccine has had data issues in its trial and the FDA is waiting on the US trial arm to finish (likely a month from now) before making a decision. The J&J vaccine has just released data and will likely be authorized in a couple weeks, but manufacturing issues mean that we won’t see tens of millions of doses until April. Novavax is in a similar boat, they won’t have much manufacturing available until late spring and their US trial only started in December so it will run until April.